FRINK Linked Data Fragments server

Matches in SemOpenAlex for { <https://semopenalex.org/work/W2571306972> ?p ?o ?g. }

• W2571306972 abstract "Asthma is a chronic respiratory disease characterized by reversible airway obstruction with persistent airway inflammation and airway remodeling, which is associated with increased airway smooth muscle (ASM) mass. Vascular endothelial growth factor (VEGF) has been implicated in inflammatory and airway blood vessel remodeling in asthma. Recent evidence indicates that a deficiency of 1,25-dihydroxyvitamin D3 (1,25(OH)2D3) may influence asthma pathogenesis. A disintegrin and metalloproteinase (ADAM)33 has been identified as playing a role in the pathophysiology of asthma. ADAM33, which is expressed in ASM cells, is suggested to play a role in the function of these cells. Recent studies show that 1,25-(OH)2D3 exerts direct inhibitory effects on passively sensitized human ASM cells in vitro, including inhibition of ADAM33 expression and cell proliferation; however, the mechanism has not been fully understood. In order to elucidate the precise mechanism underlying the effect of 1,25(OH)2D3 on VEGF-induced ADAM33 expression and ASM cell proliferation, we tested the effects of 1,25(OH)2D3 on cell cycle progression and evaluated the levels of phospho-VEGF receptor 2 (VEGFR2), phospho-extracellular signal-regulated kinase 1/2 (ERK1/2), and phospho-Akt in VEGF-stimulated ASM cells. We found that 1,25(OH)2D3 inhibited VEGF-induced ADAM33 expression and ASM cell proliferation, as well as cell cycle arrest. Additionally, VEGF-induced ADAM33 expression and ASM cell proliferation was suppressed via inhibition of ERK1/2 activity, but not that of Akt. Furthermore, 1,25(OH)2D3 treatment inhibited VEGF-induced activation of VEGFR2 as well as that of ERK and Akt in a concentration-dependent manner. 1,25(OH)2D3 also inhibited transforming growth factor (TGF)-β-induced VEGF secretion by ASM cells. Collectively, our findings suggest that 1,25(OH)2D3 inhibits VEGF-induced ASM cell proliferation by suppressing VEGFR2 and ERK1/2 activation and downregulating ADAM33. Further studies of these mechanisms are needed to facilitate the development of treatments for smooth muscle hyperplasia-associated diseases of the airway such as asthma." @default.
• W2571306972 created "2017-01-13" @default.
• W2571306972 creator A5008248463 @default.
• W2571306972 creator A5024611619 @default.
• W2571306972 creator A5035662043 @default.
• W2571306972 creator A5068765890 @default.
• W2571306972 creator A5069167592 @default.
• W2571306972 creator A5084157478 @default.
• W2571306972 date "2017-01-05" @default.
• W2571306972 modified "2023-10-17" @default.
• W2571306972 title "Effect of active vitamin D3 on VEGF-induced ADAM33 expression and proliferation in human airway smooth muscle cells: implications for asthma treatment" @default.
• W2571306972 cites W133425861 @default.
• W2571306972 cites W1604388438 @default.
• W2571306972 cites W1786542967 @default.
• W2571306972 cites W1820361434 @default.
• W2571306972 cites W1872263799 @default.
• W2571306972 cites W1948717027 @default.
• W2571306972 cites W1980820875 @default.
• W2571306972 cites W1984066690 @default.
• W2571306972 cites W1988277233 @default.
• W2571306972 cites W1996282132 @default.
• W2571306972 cites W2016068011 @default.
• W2571306972 cites W2021282800 @default.
• W2571306972 cites W2023167090 @default.
• W2571306972 cites W2025112934 @default.
• W2571306972 cites W2026115560 @default.
• W2571306972 cites W2040324906 @default.
• W2571306972 cites W2047838696 @default.
• W2571306972 cites W2049062422 @default.
• W2571306972 cites W2051082229 @default.
• W2571306972 cites W2063014521 @default.
• W2571306972 cites W2065456584 @default.
• W2571306972 cites W2070187319 @default.
• W2571306972 cites W2073870011 @default.
• W2571306972 cites W2075084409 @default.
• W2571306972 cites W2091774189 @default.
• W2571306972 cites W2091818331 @default.
• W2571306972 cites W2102818272 @default.
• W2571306972 cites W2103457206 @default.
• W2571306972 cites W2103514996 @default.
• W2571306972 cites W2104492634 @default.
• W2571306972 cites W2107919129 @default.
• W2571306972 cites W2112198605 @default.
• W2571306972 cites W2114554839 @default.
• W2571306972 cites W2127881491 @default.
• W2571306972 cites W2129349477 @default.
• W2571306972 cites W2141856502 @default.
• W2571306972 cites W2143824193 @default.
• W2571306972 cites W2160560563 @default.
• W2571306972 cites W2162565890 @default.
• W2571306972 cites W2395558749 @default.
• W2571306972 cites W2412932317 @default.
• W2571306972 cites W2415990611 @default.
• W2571306972 doi "https://doi.org/10.1186/s12931-016-0490-9" @default.
• W2571306972 hasPubMedCentralId "https://www.ncbi.nlm.nih.gov/pmc/articles/5217212" @default.
• W2571306972 hasPubMedId "https://pubmed.ncbi.nlm.nih.gov/28056993" @default.
• W2571306972 hasPublicationYear "2017" @default.
• W2571306972 type Work @default.
• W2571306972 sameAs 2571306972 @default.
• W2571306972 citedByCount "21" @default.
• W2571306972 countsByYear W25713069722017 @default.
• W2571306972 countsByYear W25713069722018 @default.
• W2571306972 countsByYear W25713069722019 @default.
• W2571306972 countsByYear W25713069722021 @default.
• W2571306972 countsByYear W25713069722022 @default.
• W2571306972 countsByYear W25713069722023 @default.
• W2571306972 crossrefType "journal-article" @default.
• W2571306972 hasAuthorship W2571306972A5008248463 @default.
• W2571306972 hasAuthorship W2571306972A5024611619 @default.
• W2571306972 hasAuthorship W2571306972A5035662043 @default.
• W2571306972 hasAuthorship W2571306972A5068765890 @default.
• W2571306972 hasAuthorship W2571306972A5069167592 @default.
• W2571306972 hasAuthorship W2571306972A5084157478 @default.
• W2571306972 hasBestOaLocation W25713069721 @default.
• W2571306972 hasConcept C124490489 @default.
• W2571306972 hasConcept C126322002 @default.
• W2571306972 hasConcept C134018914 @default.
• W2571306972 hasConcept C167734588 @default.
• W2571306972 hasConcept C179639408 @default.
• W2571306972 hasConcept C203014093 @default.
• W2571306972 hasConcept C2777025900 @default.
• W2571306972 hasConcept C502942594 @default.
• W2571306972 hasConcept C55493867 @default.
• W2571306972 hasConcept C62112901 @default.
• W2571306972 hasConcept C62478195 @default.
• W2571306972 hasConcept C71924100 @default.
• W2571306972 hasConcept C75217442 @default.
• W2571306972 hasConcept C86803240 @default.
• W2571306972 hasConcept C95444343 @default.
• W2571306972 hasConceptScore W2571306972C124490489 @default.
• W2571306972 hasConceptScore W2571306972C126322002 @default.
• W2571306972 hasConceptScore W2571306972C134018914 @default.
• W2571306972 hasConceptScore W2571306972C167734588 @default.
• W2571306972 hasConceptScore W2571306972C179639408 @default.
• W2571306972 hasConceptScore W2571306972C203014093 @default.
• W2571306972 hasConceptScore W2571306972C2777025900 @default.
• W2571306972 hasConceptScore W2571306972C502942594 @default.
• W2571306972 hasConceptScore W2571306972C55493867 @default.
• W2571306972 hasConceptScore W2571306972C62112901 @default.
• W2571306972 hasConceptScore W2571306972C62478195 @default.

• next